01 1Lusochimica SpA
01 1Metaproterenol Sulfate
01 1Italy
NDC Package Code : 43898-0106
Start Marketing Date : 1984-03-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A METAPROTERENOL SULFATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of METAPROTERENOL SULFATE, including repackagers and relabelers. The FDA regulates METAPROTERENOL SULFATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. METAPROTERENOL SULFATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of METAPROTERENOL SULFATE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A METAPROTERENOL SULFATE supplier is an individual or a company that provides METAPROTERENOL SULFATE active pharmaceutical ingredient (API) or METAPROTERENOL SULFATE finished formulations upon request. The METAPROTERENOL SULFATE suppliers may include METAPROTERENOL SULFATE API manufacturers, exporters, distributors and traders.
click here to find a list of METAPROTERENOL SULFATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing METAPROTERENOL SULFATE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for METAPROTERENOL SULFATE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture METAPROTERENOL SULFATE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain METAPROTERENOL SULFATE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a METAPROTERENOL SULFATE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of METAPROTERENOL SULFATE suppliers with NDC on PharmaCompass.
We have 1 companies offering METAPROTERENOL SULFATE
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
